Hillman Cancer Center at University of Pittsburgh Cancer Institute

Pittsburgh, Pennsylvania 15232

We've found

3 trials

at this facility

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Pittsburgh, PA

GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Pittsburgh, PA

Study of the Effect IL 7/ NT-I7 on CD4 Counts in Patients With High Grade Gliomas

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Pittsburgh, PA

Use our guide to learn which trials are right for you!